Pyxis Oncology Inc PYXS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:25 PM EDT
2.76quote price arrow down-0.16 (-5.48%)
Volume
8,808
52 week range
1.96 - 19.00
Loading...
  • Open3.00
  • Day High3.00
  • Day Low2.76
  • Prev Close2.92
  • 52 Week High19.00
  • 52 Week High Date10/08/21
  • 52 Week Low1.96
  • 52 Week Low Date05/16/22

Key Stats

  • Market Cap90.58M
  • Shares Out32.82M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-74.52

KEY STATS

  • Open3.00
  • Day High3.00
  • Day Low2.76
  • Prev Close2.92
  • 52 Week High19.00
  • 52 Week High Date10/08/21
  • 52 Week Low1.96
  • 52 Week Low Date05/16/22
  • Market Cap90.58M
  • Shares Out32.82M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-74.52

RATIOS/PROFITABILITY

  • EPS (TTM)-2.20
  • P/E (TTM)-1.25
  • Fwd P/E (NTM)-0.81
  • EBITDA (TTM)-64.685M
  • ROE (TTM)-
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pyxis Oncology Inc

There is no recent news for this security.

Profile

MORE
Pyxis Oncology, Inc. is a preclinical oncology company that is focused on developing a range of therapeutics to treat cancers. The Company has developed a portfolio of antibody drug conjugate (ADC), immuno-oncology (IO), product candidates, and monoclonal antibody (mAb), preclinical discovery programs that are developing as monotherapies and in combination with other therapies. Its pipeline includes PYX-106, PYX-102, PYX-201, PYX-202 and PYX-203. Its PYX-106 is an...
John Flavin
Independent Chairman Of The Board
Lara Sullivan M.D.
Chief Executive Officer, Director
Pamela Connealy
Chief Financial Officer
Address
35 Cambridge Park Drive, Suite 1555
Cambridge, MA
02140
United States

Top Peers

SYMBOLLASTCHG%CHG
ENLV
Enlivex Therapeutics Ltd
5.28+0.19+3.73%
EQ
Equillium Inc
2.89+0.07+2.63%
CADL
Candel Therapeutics Inc
3.55+0.19+5.50%
ANEB
Anebulo Pharmaceuticals Inc
3.80-0.05-1.30%
LIFE
aTyr Pharma Inc
3.62+0.08+2.29%